Karuna Therapeutics Appoints David Wheadon, M.D., to Its Board of Directors
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of David Wheadon, M.D., to its Board of Directors. In addition, the Company announced that Ed Harrigan, M.D., will step down from the Board of Directors effective December 3, 2020. Dr. Harrigan will continue to serve as a member of the Company’s scientific advisory board. “We are thrilled to welcome David to our Board of Directors,” said Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics. “David is a distinguished pharmaceutical leader with an extensive background in regulatory affairs, global health policy and clinical strategy. His successful track record in drug development, including several important neuropsychiatric medicines, provides an invaluable perspective as Karuna advances to late-stage clinical development and continues to grow a pipeline of novel neuropsychiatric therapies.” “I am proud to join the board of Karuna and work alongside a passionate team that is uniquely steeped in neuroscience, with first-hand experience developing medicines for those living with disabling psychiatric disorders,” stated Dr. Wheadon. “Karuna is entering an exciting phase
World News
Next-generation text analytics vendor Adoreboard adds Emotion AI to Qualtrics XM Marketplace
BELFAST, Northern Ireland, Dec. 3, 2020 /PRNewswire/ — Leading Human Experience (HX) insight platform Adoreboard has announced an integration with Qualtrics XM Platform™ empowering employee and customer experience professionals with automatic Decision Ready Insights from next-generation text analytics software Emotics. The solution enables organisations using Qualtrics XM Platform™ to upgrade their analytics from sentiment to advanced Emotion AI to understand the drivers of emotional intensity from employees or customers feedback automatically discovered in survey comments. Several Adoreboard customers using Qualtrics XM Platform™ have benefited from the integration by significantly increasing speed to insight and action for improving employee and customer experience. Healthscope, a leading private healthcare provider, with 43 private hospitals and pathology operations across Australia and New Zealand treating 600,000 patients, have benefited from the integration by using insights generated from Emotics to take action contributed to increasing patient satisfaction by 2.5 points. Jeffrey Woods, National Patient Experience Manager at Healthscope said: “Healthscope was the first private healthcare company to publicly report our patient experience data. We receive feedback from 8,000 patients monthly generating significant qualitative data with patients writing over 100 million characters in feedback. “To meet this challenge we upgraded our insight approach from binary measures such
